STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #676 by analyst upside · 2026-06-27
STTK
Shattuck Labs, Inc.
Healthcare · Market Cap $615M · P/E 0x
ANALYST PRICE TARGET
+130.3%
implied upside to consensus target
Current Price $6.44
Consensus Target $14.83
Bull Target $18.0
Bear Target $10.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
3
Hold
1
Sell
0
52-Week Low $0.71
52-Week High $8.33
YTD Return +73.6%
FUNDAMENTALS
Market Cap $615M
P/E Ratio (TTM) N/A
Forward P/E -12.5x
EPS (TTM) $-0.56
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.71
52-Week High $8.33
Current Price $6.44
Bear Target $10.0
Bull Target $18.0
● Now $6.44 ● Target $14.83
TRADING DATA
Avg Volume 725K
YTD Return +73.6%
Analyst Count 6
Consensus Buy
Upside to Target +130.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Shattuck Labs, Inc. (STTK) is currently trading at $6.44 with a Wall Street consensus price target of $14.83, implying potential upside of 130.3% over the next 12 months. 6 analysts currently cover STTK, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.0, while the most cautious has a target of $10.0.

STTK operates in the Healthcare sector with a market capitalisation of $615M. The stock is up 73.6% year-to-date and is currently trading near the upper end of its 52-week range of $0.71 – $8.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for STTK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup — Reiterated
Buy → Buy 2026-06-09 Building track record
Needham — Reiterated
Buy → Buy 2026-06-08 20% win rate (5 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-06-08 31% win rate (48 calls)
Citigroup ↑ Upgrade
Neutral → Buy 2026-06-05 Building track record
Wedbush — Reiterated
Outperform → Outperform 2026-05-08 Building track record
Cantor Fitzgerald ● Initiated
Overweight 2026-04-27 40% win rate (10 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-04-20 31% win rate (48 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-03-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
5/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →